Key takeaways from BioNTech CEO’s JPM presentation

Ugur Sahin presented a sweeping vision of the company's goal to become a next-generation immunotherapy company leveraging the messenger RNA platform technology that has won it acclaim and financial returns during the Covid-19 pandemic.